nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Chest tightness—Capecitabine—colon cancer	0.0305	0.0305	CcSEcCtD
Dimenhydrinate—Neuritis—Vincristine—colon cancer	0.0294	0.0294	CcSEcCtD
Dimenhydrinate—Euphoric mood—Fluorouracil—colon cancer	0.0176	0.0176	CcSEcCtD
Dimenhydrinate—Extrasystoles—Capecitabine—colon cancer	0.017	0.017	CcSEcCtD
Dimenhydrinate—Photosensitivity—Fluorouracil—colon cancer	0.0169	0.0169	CcSEcCtD
Dimenhydrinate—Chest discomfort—Capecitabine—colon cancer	0.0161	0.0161	CcSEcCtD
Dimenhydrinate—Urinary retention—Vincristine—colon cancer	0.0151	0.0151	CcSEcCtD
Dimenhydrinate—Irritability—Fluorouracil—colon cancer	0.0142	0.0142	CcSEcCtD
Dimenhydrinate—Sweating increased—Irinotecan—colon cancer	0.013	0.013	CcSEcCtD
Dimenhydrinate—Dysuria—Vincristine—colon cancer	0.0129	0.0129	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Vincristine—colon cancer	0.0126	0.0126	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Vincristine—colon cancer	0.012	0.012	CcSEcCtD
Dimenhydrinate—Photosensitivity—Capecitabine—colon cancer	0.0118	0.0118	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Fluorouracil—colon cancer	0.0117	0.0117	CcSEcCtD
Dimenhydrinate—Haemolytic anaemia—Capecitabine—colon cancer	0.0115	0.0115	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Fluorouracil—colon cancer	0.0112	0.0112	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Fluorouracil—colon cancer	0.0107	0.0107	CcSEcCtD
Dimenhydrinate—Diplopia—Capecitabine—colon cancer	0.0104	0.0104	CcSEcCtD
Dimenhydrinate—Irritability—Capecitabine—colon cancer	0.0099	0.0099	CcSEcCtD
Dimenhydrinate—Urinary retention—Capecitabine—colon cancer	0.00986	0.00986	CcSEcCtD
Dimenhydrinate—Chills—Irinotecan—colon cancer	0.00962	0.00962	CcSEcCtD
Dimenhydrinate—Agitation—Vincristine—colon cancer	0.0088	0.0088	CcSEcCtD
Dimenhydrinate—Photosensitivity—Methotrexate—colon cancer	0.00879	0.00879	CcSEcCtD
Dimenhydrinate—Sweating increased—Capecitabine—colon cancer	0.00873	0.00873	CcSEcCtD
Dimenhydrinate—Vertigo—Vincristine—colon cancer	0.00861	0.00861	CcSEcCtD
Dimenhydrinate—Vision blurred—Fluorouracil—colon cancer	0.00842	0.00842	CcSEcCtD
Dimenhydrinate—Vertigo—Irinotecan—colon cancer	0.00838	0.00838	CcSEcCtD
Dimenhydrinate—Dysuria—Capecitabine—colon cancer	0.00838	0.00838	CcSEcCtD
Dimenhydrinate—Convulsion—Vincristine—colon cancer	0.0083	0.0083	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Capecitabine—colon cancer	0.00818	0.00818	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Capecitabine—colon cancer	0.00783	0.00783	CcSEcCtD
Dimenhydrinate—Convulsion—Fluorouracil—colon cancer	0.00774	0.00774	CcSEcCtD
Dimenhydrinate—Confusional state—Irinotecan—colon cancer	0.00768	0.00768	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Vincristine—colon cancer	0.00766	0.00766	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Vincristine—colon cancer	0.00756	0.00756	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Capecitabine—colon cancer	0.00746	0.00746	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Irinotecan—colon cancer	0.00746	0.00746	CcSEcCtD
Dimenhydrinate—Anorexia—Vincristine—colon cancer	0.00745	0.00745	CcSEcCtD
Dimenhydrinate—Irritability—Methotrexate—colon cancer	0.00737	0.00737	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Irinotecan—colon cancer	0.00736	0.00736	CcSEcCtD
Dimenhydrinate—Confusional state—Fluorouracil—colon cancer	0.00735	0.00735	CcSEcCtD
Dimenhydrinate—Hypotension—Vincristine—colon cancer	0.00731	0.00731	CcSEcCtD
Dimenhydrinate—Anorexia—Irinotecan—colon cancer	0.00726	0.00726	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Fluorouracil—colon cancer	0.00714	0.00714	CcSEcCtD
Dimenhydrinate—Tachycardia—Fluorouracil—colon cancer	0.00712	0.00712	CcSEcCtD
Dimenhydrinate—Hypotension—Irinotecan—colon cancer	0.00712	0.00712	CcSEcCtD
Dimenhydrinate—Insomnia—Vincristine—colon cancer	0.00707	0.00707	CcSEcCtD
Dimenhydrinate—Paraesthesia—Vincristine—colon cancer	0.00702	0.00702	CcSEcCtD
Dimenhydrinate—Anorexia—Fluorouracil—colon cancer	0.00695	0.00695	CcSEcCtD
Dimenhydrinate—Insomnia—Irinotecan—colon cancer	0.00689	0.00689	CcSEcCtD
Dimenhydrinate—Paraesthesia—Irinotecan—colon cancer	0.00684	0.00684	CcSEcCtD
Dimenhydrinate—Hypotension—Fluorouracil—colon cancer	0.00682	0.00682	CcSEcCtD
Dimenhydrinate—Decreased appetite—Vincristine—colon cancer	0.0068	0.0068	CcSEcCtD
Dimenhydrinate—Somnolence—Irinotecan—colon cancer	0.00677	0.00677	CcSEcCtD
Dimenhydrinate—Fatigue—Vincristine—colon cancer	0.00674	0.00674	CcSEcCtD
Dimenhydrinate—Dyspepsia—Irinotecan—colon cancer	0.0067	0.0067	CcSEcCtD
Dimenhydrinate—Tinnitus—Capecitabine—colon cancer	0.00669	0.00669	CcSEcCtD
Dimenhydrinate—Constipation—Vincristine—colon cancer	0.00669	0.00669	CcSEcCtD
Dimenhydrinate—Decreased appetite—Irinotecan—colon cancer	0.00662	0.00662	CcSEcCtD
Dimenhydrinate—Insomnia—Fluorouracil—colon cancer	0.0066	0.0066	CcSEcCtD
Dimenhydrinate—Fatigue—Irinotecan—colon cancer	0.00657	0.00657	CcSEcCtD
Dimenhydrinate—Paraesthesia—Fluorouracil—colon cancer	0.00655	0.00655	CcSEcCtD
Dimenhydrinate—Constipation—Irinotecan—colon cancer	0.00651	0.00651	CcSEcCtD
Dimenhydrinate—Somnolence—Fluorouracil—colon cancer	0.00648	0.00648	CcSEcCtD
Dimenhydrinate—Chills—Capecitabine—colon cancer	0.00644	0.00644	CcSEcCtD
Dimenhydrinate—Dyspepsia—Fluorouracil—colon cancer	0.00642	0.00642	CcSEcCtD
Dimenhydrinate—Decreased appetite—Fluorouracil—colon cancer	0.00634	0.00634	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Irinotecan—colon cancer	0.00628	0.00628	CcSEcCtD
Dimenhydrinate—Dysuria—Methotrexate—colon cancer	0.00624	0.00624	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Methotrexate—colon cancer	0.00609	0.00609	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Fluorouracil—colon cancer	0.00601	0.00601	CcSEcCtD
Dimenhydrinate—Drowsiness—Methotrexate—colon cancer	0.00595	0.00595	CcSEcCtD
Dimenhydrinate—Vision blurred—Capecitabine—colon cancer	0.00589	0.00589	CcSEcCtD
Dimenhydrinate—Tremor—Capecitabine—colon cancer	0.00585	0.00585	CcSEcCtD
Dimenhydrinate—Urticaria—Fluorouracil—colon cancer	0.00579	0.00579	CcSEcCtD
Dimenhydrinate—Vertigo—Capecitabine—colon cancer	0.00561	0.00561	CcSEcCtD
Dimenhydrinate—Asthenia—Vincristine—colon cancer	0.00561	0.00561	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Methotrexate—colon cancer	0.00555	0.00555	CcSEcCtD
Dimenhydrinate—Palpitations—Capecitabine—colon cancer	0.00552	0.00552	CcSEcCtD
Dimenhydrinate—Asthenia—Irinotecan—colon cancer	0.00546	0.00546	CcSEcCtD
Dimenhydrinate—Diarrhoea—Vincristine—colon cancer	0.00535	0.00535	CcSEcCtD
Dimenhydrinate—Diarrhoea—Irinotecan—colon cancer	0.00521	0.00521	CcSEcCtD
Dimenhydrinate—Dry mouth—Capecitabine—colon cancer	0.0052	0.0052	CcSEcCtD
Dimenhydrinate—Dizziness—Vincristine—colon cancer	0.00517	0.00517	CcSEcCtD
Dimenhydrinate—Confusional state—Capecitabine—colon cancer	0.00514	0.00514	CcSEcCtD
Dimenhydrinate—Dizziness—Irinotecan—colon cancer	0.00504	0.00504	CcSEcCtD
Dimenhydrinate—Diarrhoea—Fluorouracil—colon cancer	0.00499	0.00499	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Capecitabine—colon cancer	0.00499	0.00499	CcSEcCtD
Dimenhydrinate—Tinnitus—Methotrexate—colon cancer	0.00498	0.00498	CcSEcCtD
Dimenhydrinate—Tachycardia—Capecitabine—colon cancer	0.00497	0.00497	CcSEcCtD
Dimenhydrinate—Vomiting—Vincristine—colon cancer	0.00497	0.00497	CcSEcCtD
Dimenhydrinate—Rash—Vincristine—colon cancer	0.00493	0.00493	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Capecitabine—colon cancer	0.00493	0.00493	CcSEcCtD
Dimenhydrinate—Dermatitis—Vincristine—colon cancer	0.00493	0.00493	CcSEcCtD
Dimenhydrinate—Headache—Vincristine—colon cancer	0.0049	0.0049	CcSEcCtD
Dimenhydrinate—Anorexia—Capecitabine—colon cancer	0.00486	0.00486	CcSEcCtD
Dimenhydrinate—Vomiting—Irinotecan—colon cancer	0.00484	0.00484	CcSEcCtD
Dimenhydrinate—Dizziness—Fluorouracil—colon cancer	0.00482	0.00482	CcSEcCtD
Dimenhydrinate—Rash—Irinotecan—colon cancer	0.0048	0.0048	CcSEcCtD
Dimenhydrinate—Dermatitis—Irinotecan—colon cancer	0.0048	0.0048	CcSEcCtD
Dimenhydrinate—Chills—Methotrexate—colon cancer	0.00479	0.00479	CcSEcCtD
Dimenhydrinate—Headache—Irinotecan—colon cancer	0.00477	0.00477	CcSEcCtD
Dimenhydrinate—Hypotension—Capecitabine—colon cancer	0.00476	0.00476	CcSEcCtD
Dimenhydrinate—Nausea—Vincristine—colon cancer	0.00464	0.00464	CcSEcCtD
Dimenhydrinate—Vomiting—Fluorouracil—colon cancer	0.00464	0.00464	CcSEcCtD
Dimenhydrinate—Insomnia—Capecitabine—colon cancer	0.00461	0.00461	CcSEcCtD
Dimenhydrinate—Rash—Fluorouracil—colon cancer	0.0046	0.0046	CcSEcCtD
Dimenhydrinate—Dermatitis—Fluorouracil—colon cancer	0.00459	0.00459	CcSEcCtD
Dimenhydrinate—Paraesthesia—Capecitabine—colon cancer	0.00458	0.00458	CcSEcCtD
Dimenhydrinate—Headache—Fluorouracil—colon cancer	0.00457	0.00457	CcSEcCtD
Dimenhydrinate—Nausea—Irinotecan—colon cancer	0.00452	0.00452	CcSEcCtD
Dimenhydrinate—Dyspepsia—Capecitabine—colon cancer	0.00449	0.00449	CcSEcCtD
Dimenhydrinate—Decreased appetite—Capecitabine—colon cancer	0.00443	0.00443	CcSEcCtD
Dimenhydrinate—Fatigue—Capecitabine—colon cancer	0.00439	0.00439	CcSEcCtD
Dimenhydrinate—Vision blurred—Methotrexate—colon cancer	0.00438	0.00438	CcSEcCtD
Dimenhydrinate—Constipation—Capecitabine—colon cancer	0.00436	0.00436	CcSEcCtD
Dimenhydrinate—Nausea—Fluorouracil—colon cancer	0.00433	0.00433	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Capecitabine—colon cancer	0.0042	0.0042	CcSEcCtD
Dimenhydrinate—Vertigo—Methotrexate—colon cancer	0.00418	0.00418	CcSEcCtD
Dimenhydrinate—Urticaria—Capecitabine—colon cancer	0.00405	0.00405	CcSEcCtD
Dimenhydrinate—Convulsion—Methotrexate—colon cancer	0.00403	0.00403	CcSEcCtD
Dimenhydrinate—Confusional state—Methotrexate—colon cancer	0.00383	0.00383	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Methotrexate—colon cancer	0.00371	0.00371	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Methotrexate—colon cancer	0.00367	0.00367	CcSEcCtD
Dimenhydrinate—Asthenia—Capecitabine—colon cancer	0.00366	0.00366	CcSEcCtD
Dimenhydrinate—Anorexia—Methotrexate—colon cancer	0.00362	0.00362	CcSEcCtD
Dimenhydrinate—Hypotension—Methotrexate—colon cancer	0.00355	0.00355	CcSEcCtD
Dimenhydrinate—Diarrhoea—Capecitabine—colon cancer	0.00349	0.00349	CcSEcCtD
Dimenhydrinate—Insomnia—Methotrexate—colon cancer	0.00343	0.00343	CcSEcCtD
Dimenhydrinate—Paraesthesia—Methotrexate—colon cancer	0.00341	0.00341	CcSEcCtD
Dimenhydrinate—Somnolence—Methotrexate—colon cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Dizziness—Capecitabine—colon cancer	0.00337	0.00337	CcSEcCtD
Dimenhydrinate—Dyspepsia—Methotrexate—colon cancer	0.00334	0.00334	CcSEcCtD
Dimenhydrinate—Decreased appetite—Methotrexate—colon cancer	0.0033	0.0033	CcSEcCtD
Dimenhydrinate—Fatigue—Methotrexate—colon cancer	0.00327	0.00327	CcSEcCtD
Dimenhydrinate—Vomiting—Capecitabine—colon cancer	0.00324	0.00324	CcSEcCtD
Dimenhydrinate—Rash—Capecitabine—colon cancer	0.00321	0.00321	CcSEcCtD
Dimenhydrinate—Dermatitis—Capecitabine—colon cancer	0.00321	0.00321	CcSEcCtD
Dimenhydrinate—Headache—Capecitabine—colon cancer	0.00319	0.00319	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Methotrexate—colon cancer	0.00313	0.00313	CcSEcCtD
Dimenhydrinate—Nausea—Capecitabine—colon cancer	0.00303	0.00303	CcSEcCtD
Dimenhydrinate—Urticaria—Methotrexate—colon cancer	0.00301	0.00301	CcSEcCtD
Dimenhydrinate—Asthenia—Methotrexate—colon cancer	0.00272	0.00272	CcSEcCtD
Dimenhydrinate—Diarrhoea—Methotrexate—colon cancer	0.0026	0.0026	CcSEcCtD
Dimenhydrinate—Dizziness—Methotrexate—colon cancer	0.00251	0.00251	CcSEcCtD
Dimenhydrinate—Vomiting—Methotrexate—colon cancer	0.00241	0.00241	CcSEcCtD
Dimenhydrinate—Rash—Methotrexate—colon cancer	0.00239	0.00239	CcSEcCtD
Dimenhydrinate—Dermatitis—Methotrexate—colon cancer	0.00239	0.00239	CcSEcCtD
Dimenhydrinate—Headache—Methotrexate—colon cancer	0.00238	0.00238	CcSEcCtD
Dimenhydrinate—Nausea—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
